STATEN ISLAND, N.Y., Nov. 20, 2024 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“we” or “Acurx” or the “Company”), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the Company’s […]
Tag: Biotechnology
Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer
Ampersand’s AND™ Platform will be used to identify programmed biologics for the treatment of obesity-related targets Montai’s CONECTA™ AI platform will be used to identify small molecules directed to a potential Non-Small Cell Lung Cancer-related target […]
Nagase Viita lanzará el excipiente farmacéutico inyectable «SUCROSE SG» en 2025
OKAYAMA, Japón, 20 de noviembre de 2024 /PRNewswire/ — Nagase Viita Co., Ltd., miembro del Grupo NAGASE con sede en Okayama (Japón), se dispone a ampliar la línea de SOLBIOTE (TM), excipientes farmacéuticos a base […]
FDA Roundup: November 19, 2024
SILVER SPRING, Md., Nov. 19, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued a request for information (RFI) […]
Preimplantation Genetic Testing Market Set to Reach $1.2 Billion by 2031, Driven by Advances in Genetic Screening and Growing IVF Demand: Market Research Intellect
The growth of the Preimplantation Genetic Testing market is driven by increasing demand for in vitro fertilization (IVF) treatments and rising awareness of genetic disorders. Technological advancements in genetic screening are enhancing the accuracy of […]